Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mona S. Gouida"'
Publikováno v:
Heliyon, Vol 8, Iss 5, Pp e09474- (2022)
Background: Breast cancer (BC) is considered as a common type of cancer threatening women throughout the world. Therefore, development of early predication biomarkers for BC got more concern especially for Egyptian females. This study was aimed to ev
Externí odkaz:
https://doaj.org/article/53d19cf388b749dd9131c4388ae83674
Autor:
Safaa A. Derbala, Mona S. Gouida
Publikováno v:
Biochemistry Letters. 18:73-84
Autor:
Samah I. Ghoname, Hoda E. L. Sayed, Ibrahim Aly, Noha A. Elleboudy, Shaimaa Shaker, Mona S. Gouida, Sama M. N. Attiyah
Publikováno v:
Journal of Pharmaceutical Research International. :31-41
Schistosomias is a prevalent parasitic disease in tropical and sub-tropical areas, which comes in the second place in terms of socioeconomic and public health burden. Around 600 million people in 74 countries are infected yearly, predominantly in the
Publikováno v:
Journal of Food Biochemistry. 46
Hepatocellular carcinoma (HCC) is a lethal disease, and in HCC advanced stages, there is limited therapeutic efficacy. HCC results in a complication of fibrosis or cirrhosis. In this study, the protective effect of curcumin and selenium versus hepato
Publikováno v:
Indian J Hematol Blood Transfus
Cluster of differentiation 96 (CD96) is an important leukemic stem cells (LSCs) surface marker. We evaluated CD96 expression in children with acute leukemia (AL) and described its relation with treatment response. We conducted a prospective cohort st
Publikováno v:
Central European Journal of Immunology, Vol 43, Iss 3, Pp 248-254 (2018)
Central-European Journal of Immunology
Central-European Journal of Immunology
Down syndrome (DS) is the commonest genetic disorder and more liable for recurrent infections. We aimed to determine the differences in lymphocyte subgroups between DS children and the healthy population and to study the pattern and likelihood for re
Publikováno v:
BIOCELL. 42:55-60
Hepatitis C virus (HCV)-cirrhotic patients have the highest threat of developing hepatocellular carcinoma (HCC) and may be at risk of extra hepatic cancer. The present study was designed to investigate CD133 and CK19 in HCV (genotype-4)-cirrhotic pat
Publikováno v:
Biochemistry Letters. 12:40-48
Autor:
Ali Amin, Azza I. Othman, Doaa A. Ali, Ahmed H. Ismail, Mohamed A. El-Missiry, Mona S. Gouida
Publikováno v:
Journal of pineal research. 67(2)
The current work estimated the antitumour efficacy of melatonin (MLT) on the growth of Ehrlich ascites carcinoma cells inoculated intramuscularly into the hind limbs of female BALB/c mice and to compare its effects with those of adriamycin (ADR). Aft
Autor:
Faten R. Abdel Ghaffar, Ibrahim A. El-Elaimy, Mona S. Gouida, Hany M. Ibrahim, Heba M. Abd El latif
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 106
Many alternative and complementary therapies for cancer have been reported. The objective of the present work is to examine antitumor and immune-modulatory properties of dual-treatment based on levamisole (Lms) and/or taurine (Tau) in Ehrlich ascites